The effects of BAFF and APRIL signaling on non-small cell lung cancer cell proliferation and invasiveness.

Autor: Warakomska M; Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, 15-269 Bialystok, Poland., Tynecka M; Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, 15-269 Bialystok, Poland., Lemancewicz D; Department of Human Anatomy, Medical University of Bialystok, 15-230 Bialystok, Poland.; Department of Haematology, Medical University of Bialystok, 15-276 Bialystok, Poland., Grubczak K; Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, 15-269 Bialystok, Poland., Dzieciol J; Department of Human Anatomy, Medical University of Bialystok, 15-230 Bialystok, Poland., Moniuszko M; Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, 15-269 Bialystok, Poland.; Department of Allergology and Internal Medicine, Medical University of Bialystok, 15-276 Bialystok, Poland., Eljaszewicz A; Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, 15-269 Bialystok, Poland., Bolkun L; Department of Human Anatomy, Medical University of Bialystok, 15-230 Bialystok, Poland.
Jazyk: angličtina
Zdroj: Oncology letters [Oncol Lett] 2021 Oct; Vol. 22 (4), pp. 728. Date of Electronic Publication: 2021 Aug 10.
DOI: 10.3892/ol.2021.12989
Abstrakt: Lung cancer represents the most common type of human malignancy and is the main cause of cancer-associated mortality worldwide. To improve the effectiveness of treatment strategies, a better understanding of the mechanisms of cancer progression and invasiveness is required. Recently, B-cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), two relatively newly described cytokines belonging to the tumor necrosis factor superfamily, have been shown to play a role in cancer progression. However, at present, the effects of both cytokines on lung cancer cells remain unclear. The present study aimed therefore to understand the direct effects of BAFF and APRIL on non-small cell lung cancer (NSCLC) progression. To do so, reverse transcription quantitative PCR and western blotting were used to evaluate whether A549 and H2030 NSCLC cells express receptors for both BAFF and APRIL. The results demonstrated that both investigated cell lines expressed BAFF-R (receptor specific to BAFF only) and transmembrane activator and CAML interactor (TACI; shared receptor for both cytokines). In addition, functional experiments were performed to determine the effects of BAFF and APRIL stimulation on cancer cell viability. The results demonstrated no direct effects of BAFF and APRIL on NSCLC cell proliferation and invasiveness. In summary, the present study demonstrated that NSCLC cells possess the ability to respond directly to both BAFF and APRIL. However, activation of BAFF-R and TACI signaling in cancer cells did not increase the proliferative capacity and invasiveness. Further investigation is thus required to better understand the role of BAFF and APRIL on the progression of NSCLC.
Competing Interests: The authors declare that they have no competing interests.
(Copyright © 2021, Spandidos Publications.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje